BioCentury
ARTICLE | Company News

Praecis seeking EU Plenaxis approval

June 23, 2003 7:00 AM UTC

PRCS submitted an MAA for EU approval of its Plenaxis abarelix to treat hormone responsive prostate cancer. The MAA was submitted in Germany under the Mutual Recognition Procedure. PRCS resubmitted an...